Company intelligence / Profile preview

Sunshine Heart

Eden Prairie, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Sunshine Heart (now CHF Solutions) developed the C-Pulse Heart Assist System, a non-blood-contacting heart assist device for moderate-to-severe heart failure. The device completed an FDA feasibility study and started a pivotal trial (COUNTER HF) in the US. CE Mark was granted in Europe, indicating completion of key safety and efficacy studies. Early data suggested improvement in symptoms and possible functional recovery in certain cases.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Silicon Valley Bank (lender for pivotal study funding)

Beyond the preview

Go deeper on Sunshine Heart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunshine Heart.

Explore the full profile